Skip to main navigation Skip to search Skip to main content

Suitability of the woodchuck HCC as a preclinical model for evaluation of intra-arterial therapies

  • Alexander Y. Kim
  • , Joseph H. Yacoub
  • , David H. Field
  • , Byoung Uk Park
  • , Bhaskar Kallakury
  • , Kyle E. Korolowicz
  • , Stephan Menne

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The most commonly used preclinical models of hepatocellular carcinoma (HCC) are limited for use in testing of intra-arterial therapies such as transarterial chemoembolization and radioembolization. Issues encountered with the more commonly used animal models include dissimilarity in their disease development compared with humans and the size of the vasculature which can make intra-arterial therapy testing difficult or impossible. Here we describe the suitability of the woodchuck HCC model for testing of intra-arterial therapies. We describe the techniques for pre-embolization imaging assessment using CT and MRI, technical tips on performing angiography and embolization, and pathological assessment of treated liver.

Original languageEnglish (US)
Pages (from-to)98-102
Number of pages5
JournalAnimal Models and Experimental Medicine
Volume3
Issue number1
DOIs
StatePublished - Mar 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • angiography
  • animal model
  • hepatocellular carcinoma
  • woodchuck

Fingerprint

Dive into the research topics of 'Suitability of the woodchuck HCC as a preclinical model for evaluation of intra-arterial therapies'. Together they form a unique fingerprint.

Cite this